Status:
COMPLETED
Use of Virtual Reality to Reduce Morphine Consumption in Adolescents Undergoing Scoliosis Surgery
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Scoliosis
Eligibility:
All Genders
13-18 years
Phase:
NA
Brief Summary
The objective is to evaluate the effect of the association of virtual reality sessions with usual management on the cumulative consumption of morphine equivalent post-operatively in adolescents aged 1...
Eligibility Criteria
Inclusion
- Patient between 13 and 18 years old, i.e. the age to use a virtual reality helmet according to the manufacturer's recommendations.
- Patient with an indication for idiopathic scoliosis surgery.
- Free, informed and signed consent by patients (or parents/parental guardians) and the investigator (no later than the day of inclusion and prior to any review required by the research)
Exclusion
- Patient undergoing surgery for neurological scoliosis.
- Impossibility to use the VR helmet (blindness, eye infection, helmet wound, epilepsy, psychiatric or cognitive disorder incompatible with VR).
- History of adverse effects while wearing an VR helmet (nausea, vomiting, headache, visual disturbances)
- Patient with a contraindication to the use of morphinics
- Patient whose both parents benefit from a legal protection measure (guardianship, curatorship, safeguard of justice)
Key Trial Info
Start Date :
February 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 24 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04892940
Start Date
February 21 2022
End Date
July 24 2024
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Toulouse
Toulouse, France